Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jones

Showing results (591-600 of 654) with videos related to

Pageof 66
Sort By:
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung AdenocarcinomaJian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
EMBO Molecular Medicine|April 6, 2021
Delivery of oligonucleotide-based therapeutics: challenges and opportunitiesSuzan M Hammond, Annemieke Aartsma-Rus, Sandra Alves, et al.
The Oncologist|May 27, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L Hertz, Allison Deal, Joseph G Ibrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Cell|July 16, 2003
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptorOr Gozani, Philip Karuman, David R Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
STAR Protocols|March 31, 2021
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluidsLinda Bojmar, Han Sang Kim, Gabriel C Tobias, et al.
Pageof 66

Showing results (591-600 of 654) with videos related to

Sort By:
Pageof 66
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung AdenocarcinomaJian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
EMBO Molecular Medicine|April 6, 2021
Delivery of oligonucleotide-based therapeutics: challenges and opportunitiesSuzan M Hammond, Annemieke Aartsma-Rus, Sandra Alves, et al.
The Oncologist|May 27, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L Hertz, Allison Deal, Joseph G Ibrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Cell|July 16, 2003
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptorOr Gozani, Philip Karuman, David R Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
STAR Protocols|March 31, 2021
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluidsLinda Bojmar, Han Sang Kim, Gabriel C Tobias, et al.
Pageof 66